C4X Discovery Limited
Other research and experimental development on natural sciences and engineering · Leeds
ActiveUnited KingdomIncorporated 2007Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2008-07-31
XBRL · 30 source facts · 8 selected values
Not assessedlegacy record
Accounts to 2008-07-31
XBRL · 30 source facts · 8 selected values
Not assessed
legacy record
- Reporting period
- — to —
- Extraction status
- Legacy / not assessed
- Numeric facts
- 17
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-ae-2008-04-06.xsd
- Currency
- GBP
- Source identifier
- Prod224_8999_06324250_20080731
- Source archive
- Accounts_Monthly_Data-JanuaryToDecember2009.zip
Registered details
06324250- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2007-07-25
- Jurisdiction
- —
- Registered office
- 1, PARK ROW, LEEDS, LS1 5AB, UNITED KINGDOM
Classification
1 SIC codes72190
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
8 matched grantsThe University of Manchester and C4X Discovery LimitedInnovate UK · Knowledge Transfer Partnership · 2019-05-01 – 2022-06-30 · with 1 other participant
The University of Manchester and C4X Discovery Limited
Innovate UK · Knowledge Transfer Partnership · 2019-05-01 – 2022-06-30 · with 1 other participant
C4X Discovery Limited—
Harnessing the synergy between Conformetrix technology and crystallography to expedite identification of novel, selective a4b7 integrin inhibitors for the treatment of IBDLead
Innovate UK · Feasibility Studies · 2018-11-01 – 2019-09-30
£139,965
awarded
Analysis of Methyltransferase BUD23 in Energy MetabolismMRC · Studentship · 2017-09-30 – 2021-03-30 · with 2 other participants£0whole project
Analysis of Methyltransferase BUD23 in Energy Metabolism
MRC · Studentship · 2017-09-30 – 2021-03-30 · with 2 other participants
£0
whole project
University Of OxfordleadC4X Discovery LtdC4X Discovery (United Kingdom)
Oral Agonists of GPR142, an Innovative New Target for the Treatment of Type 2 DiabetesLead
Innovate UK · Feasibility Studies · 2017-01-01 – 2017-12-31
£139,640
awarded
Rational design of glycan-based drugs for inflammatory diseaseBBSRC · Studentship · 2016-09-30 – 2021-01-31 · with 2 other participants£0whole project
Rational design of glycan-based drugs for inflammatory disease
BBSRC · Studentship · 2016-09-30 – 2021-01-31 · with 2 other participants
£0
whole project
C4X Discovery - Validation of GPR142 as a Target for Type II DiabetesLead
Innovate UK · GRD Proof of Concept · 2015-04-01 – 2015-12-31
£59,954
awarded
Small-molecule agonists of GLP-1R for the treatment of Type-2 diabetesLead
Innovate UK · Feasibility Studies · 2014-07-01 – 2015-09-30
£148,293
awarded
Structure-based rational design of oligonucleotide-mediated chemical ribonucleasesEPSRC · Research Grant · 2007-01-01 – 2009-06-29 · with 3 other participants£205,914whole project
Structure-based rational design of oligonucleotide-mediated chemical ribonucleases
EPSRC · Research Grant · 2007-01-01 – 2009-06-29 · with 3 other participants
£205,914
whole project